Latest Obsessive–compulsive disorder Stories
Jedidiah Becker for redOrbit.com – Your Universe Online One of the most unusual and little understood psychiatric disorders is a condition known as body dysmorphic disorder, or BDD. Individuals afflicted with this disease believe they are disfigured or extremely unattractive despite appearing normal to other people. Now, researchers at UCLA have shed light on the neurological underpinnings of this bizarre disorder, and they say the condition arises from abnormal wiring across vast...
OCD Rescue Program is the latest OCD treatment method developed by Rich Presta that promises to help people lower Obsessive Compulsive Disorder. A full OCD Rescue Program review on the website Vkool.com indicates if the method is effective for people to use. Seattle, WA (PRWEB) April 27, 2013 OCD Rescue Program is the newly updated OCD treatment method created by Rich Presta that promises to enable users to reduce Obsessive Compulsive Disorder (OCD). The natural method is based on the...
Peter Suciu for redOrbit.com – Your Universe Online Even as spring has arrived on the calendar for much of the country this winter might seem almost unending. That is bad news for those suffering from seasonal affective disorder (SAD), a type of depression that occurs around the same time each year. It can sap the energy and make those with the disorder feel moody. It could also have more people heading to the computer to determine if they might be suffering from a mental illness as...
The trending popularity of hoarding continues to surge as more hoarders become aware that others share their debilitating condition. Address Our Mess offers their expert opinion to hoarders taking the first step of a program recently initiated by the Dean of Boston University School of Social Work. Mount Laurel, New Jersey (PRWEB) April 05, 2013 Hoarding awareness is becoming more prevalent in a society where documentaries and social media make it easier for sufferers of the condition to...
Company Awarded 180 Days Marketing Exclusivity for 150 mg Strength WOODCLIFF LAKE, N.J., March 14, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for fluvoxamine maleate 100 mg and 150 mg extended-release (ER) capsules. Fluvoxamine maleate ER is the generic version of Jazz Pharmaceuticals' Luvox CR(®) and is indicated for the...
April Flowers for redOrbit.com - Your Universe Online A new mom is full of worries. She checks to see if the baby is breathing or she worries about germs – washing and re-sterilizing bottles to make sure they are clean. A new baby, especially the first one, seems so fragile that worrying becomes a way of life. A new study from Northwestern Medicine reveals women who have recently given birth have a much higher rate of obsessive-compulsive symptoms than the general population. In...
Jeanne Ettelson, president of Beyond OCD, announced that OCD expert Mona H. Berman and two teens successfully recovering from OCD will be the first speakers of the 2013 OCD Live Forum series. Chicago, IL (PRWEB) February 12, 2013 Mona H. Berman, a private practitioner in Northfield, IL for 18 years, will kick off Beyond OCD’s 2013 OCD Live Forum series. This series is intended to educate OCD sufferers and their families about treatment options and the latest advances in the field. Ms....
OCONOMOWOC, Wis., Jan. 29, 2013 /PRNewswire/ -- The results of a recent outcome study held at Rogers Memorial Hospital have been published by Routledge, Taylor & Francis Group in its journal - Cognitive Behaviour Therapy. Pulled from data for patients admitted to Rogers' Eating Disorder Center (EDC) from 2006-2011, the research indicates that simultaneous treatment of obsessive-compulsive disorder (OCD) and eating disorders can be more effective with a multi-modal approach....
POINT RICHMOND, Calif., Dec. 21, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced initial top-line results from its Phase 2 clinical trial evaluating the efficacy and safety of TO-2061 (ondansetron oral tablets 0.5 mg and 0.75 mg) in patients with obsessive compulsive disorder (OCD) who had not adequately responded to treatment with approved first-line therapies. The data from the trial showed that TO-2061 did not meet the primary efficacy endpoint...
CHICAGO, Dec. 5, 2012 /PRNewswire/ -- Postpartum depression has long been seen as a problem, but mental health providers say anxiety - not just depression - seems to be a major challenge facing new mothers today. Mental health experts in Chicago are identifying an increasing number of patients who are experiencing severe anxiety and obsessive compulsive symptoms after childbirth. "We're seeing moms with disabling anxiety, not just depression after giving birth," says Vesna Pirec,...
